| |
| |
|
| Insider
Information: |
Bilinsky Igor |
| Relationship: |
Chief Operating Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
231,824 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$649,302 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
231,824 |
|
|
| Total
Value |
$649,302 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Sr VP, Corporate Devel... |
2015-07-13 |
193,798 |
|
0 |
Premium* |
|
|
Iovance Biotherapeutics Inc |
IOVA |
Chief Operating Officer |
2024-04-15 |
38,026 |
2022-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2024-04-15 |
4 |
D |
$11.89 |
$16,967 |
D/D |
(1,427) |
38,026 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
39,453 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2024-03-04 |
4 |
D |
$16.96 |
$123,588 |
D/D |
(7,287) |
36,641 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,061 |
43,928 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2024-01-16 |
4 |
D |
$8.37 |
$13,199 |
D/D |
(1,577) |
29,867 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
31,444 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-10-16 |
4 |
D |
$3.57 |
$4,980 |
D/D |
(1,395) |
28,631 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-10-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
30,026 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-07-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
28,608 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-07-14 |
4 |
D |
$7.76 |
$10,825 |
D/D |
(1,395) |
27,213 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-04-14 |
4 |
D |
$5.64 |
$7,868 |
D/D |
(1,395) |
25,795 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
27,190 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-01-17 |
4 |
D |
$6.43 |
$30,035 |
D/D |
(4,671) |
24,378 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,248 |
29,049 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
D |
$6.11 |
$64,479 |
D/D |
(10,553) |
17,801 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,850 |
28,354 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2022-06-14 |
4 |
D |
$7.73 |
$72,245 |
D/D |
(9,346) |
9,504 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
• – – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,850 |
18,850 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Sr VP, Corporate Development |
• – – |
2015-07-13 |
4 |
AS |
$0.70 |
$879 |
D/D |
(1,258) |
193,798 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Sr VP, Corporate Development |
• – – |
2015-04-13 |
4 |
AS |
$0.93 |
$1,173 |
D/D |
(1,257) |
195,056 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Sr VP, Corporate Development |
• – – |
2015-01-19 |
4 |
A |
$0.01 |
$700 |
D/D |
70,000 |
196,313 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Sr VP, Corporate Development |
• – – |
2015-01-12 |
4 |
AS |
$1.16 |
$1,544 |
D/D |
(1,335) |
126,313 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Sr VP, Corporate Development |
• – – |
2014-10-13 |
4 |
AS |
$1.08 |
$1,446 |
D/D |
(1,335) |
127,648 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Senior VP, Corporate Devt |
• – – |
2014-08-26 |
4 |
AS |
$1.25 |
$15,671 |
D/D |
(12,500) |
128,983 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Senior VP, Corporate Devt |
• – – |
2014-07-11 |
4 |
AS |
$1.16 |
$1,554 |
D/D |
(1,335) |
141,483 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
